MIAMI – January15, 2019 – Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services andtechnology company, today announced further growth year-over-year in revenueand number of prescriptions filled for December 2018.
In December, thecompany reported a total of $1.7 million in net revenue, a 6% increase from thesame month last year, and a 45% increase in prescriptions filled during thesame month last year, totaling nearly 28,332 prescriptions filled. This marksthe strongest finish to the year in Company history.
“December was another big month forus. Progressive Care exceeded December 2017 prescription fillings and is movingforward on major initiatives,” said S. Parikh Mars, CEO of Progressive Care. “InDecember, we finalized the closing of our first property and are eagerlypushing forward on an agenda that will capitalize on our many achievements in2018. We are confident that 2019 will lead to continued growth, morerecord-breaking months, and even bigger milestones while we continue our highstandards for patient service and value-added healthcare management offerings.”
Connect and stay in touch with uson social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health servicesorganization and provider of prescription pharmaceuticals, compoundedmedications, provider of tele-pharmacy services, the sale of anti-retroviralmedications, medication therapy management (MTM), the supply of prescriptionmedications to long-term care facilities, and health practice risk management.
Cautionary Statement RegardingForward-Looking Statements
Statements contained herein thatare not based upon current or historical fact are forward-looking in nature andconstitute forward-looking statements within the meaning of Section 27A of theSecurities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.Such forward-looking statements reflect the Company’s expectations about itsfuture operating results, performance, and opportunities that involvesubstantial risks and uncertainties. These statements include but are notlimited to statements regarding the intended terms of the offering, closing ofthe offering and use of any proceeds from the offering. When used herein, thewords “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,”“intend” and “expect” and similar expressions, as they relate to ProgressiveCare Inc., its subsidiaries, or its management, are intended to identify suchforward-looking statements. These forward-looking statements are based oninformation currently available to the Company and are subject to a number ofrisks, uncertainties, and other factors that could cause the Company’s actualresults, performance, prospects, and opportunities to differ materially fromthose expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, ProgressiveCare
Senior Advisor BusinessDevelopment
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Kathleen Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Web and Application DevelopmentContact:
Marcello Jaspan, Mass VenturesCorp
Marcello@massventurescorp.comwww.massventurescorp.com
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!